Abstract: An anti-inflammatory peptide was identified in lupine protein hydrolysate (LPH) obtained by enzymatic hydrolysis of lupine protein isolate (LPI) with Alcalase. LPH was separated in two fractions by ultrafiltration, and anti-inflammatory activity was evaluated by analysis of the expression of different cytokines in THP-1-derived macrophages by quantitative PCR (qPCR). Fraction <10 kDa was purified by chromatographic techniques, and the most active subfraction was analysed by mass spectrometry. A novel anti-inflammatory peptide was identified and the sequence was Gly-Pro-GluThr-Ala-Phe-Leu-Arg. This peptide was synthesised, and its anti-inflammatory activity was tested at two concentrations. Expression of TNF, IL-1β, and CCL2 was significantly reduced whereas the expression of the anti-inflammatory cytokine IL-10 was induced. Regarding the production of cytokines, only the lowest concentration of the synthetic peptide showed anti-inflammatory properties. Furthermore, the synthetic peptide decreased nitric oxide production. Thus, the identified peptide may help to prevent chronic inflammation associated with several diseases.
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Introduction
Proteins are an essential source of energy and amino acids. In addition to nutritional value, dietary proteins serve many functions in vivo by means of biologically active peptides (Sharma, Singh, & Rana, 2011) . Bioactive peptides are small amino acid sequences that are inactive in the native protein but can be released by digestive enzymes during gastrointestinal transit, by fermentation or ripening during food processing, and by proteolysis by enzymes derived from microorganisms, plants, or animals. Until now, milk proteins have been considered as the most important source of bioactive peptides (Korhonen, 2009) . Plant proteins are less expensive and therefore a valuable alternative for the production of bioactive peptides derived from dietary protein (Aluko, 2008) . Legumes and cereals are the main source of plant proteins in the human diet. Among legumes, soybean and lupine stand out for their protein content (35-40%) from others such as pea or chickpea that do not exceed 30% (Day, 2013) . Various biological activities have been attributed to lupine proteins, but hypocholesterolaemic and antioxidant activities have been studied the most extensively to date (Yoshie -Stark 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   4 properties (Mao, Cheng, Wang, & Wu, 2011; Ndiaye, Vuong, Duarte, Aluko, & Matar, 2012) . Although different plant protein hydrolysates have shown anti-inflammatory properties (Oseguera-Toledo, Gonzalez de Mejia, Dia, & Amaya-Llano, 2011; Ndiaye et al., 2012; McCarthy, O'Callaghan, Connolly, Piggott, FitzGerald, & O'Brien, 2013) , few specific peptides have been isolated from them. The most studied plant antiinflammatory peptide is lunasin, a 43-amino acid chemopreventive peptide which has been isolated from soybean, barley, wheat, rye and triticale (Dinelli et al., 2014) . It has been reported that lunasin from soybean inhibits inflammation in LPS-induced RAW 264.7 macrophage by suppressing NK-κΒ pathway (Gonzalez de Mejia, & Dia, 2009) .
We have previously shown that lupine protein hydrolysates (LPHs) present potential anti-inflammatory activity by the inhibition of enzymes involved in the inflammation pathway (Millán-Linares, Yust, Alcaide-Hidalgo, Millán, & Pedroche, 2014) and the reduction of pro-inflammatory cytokine expression in THP-1-derived macrophages (Millán-Linares, Bermúdez, Yust, Millán, & Pedroche, 2014) . The aim of this work was to detect the peptide or peptides responsible for the anti-inflammatory activity of LPHs.
An octapeptide was identified and it was synthesised, and the anti-inflammatory activity was evaluated by measuring the expression and production of the pro-inflammatory cytokines TNF, IL-1β, IL-6, C-C chemokine receptor type 2 (CCR2), chemokine (C-C motif) ligand 2 (CCL2), and the anti-inflammatory cytokines chemokine (C-C motif) ligand 18 (CCL18), and IL10. Moreover, the effect of the peptide on nitric oxide production was also evaluated. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 
Materials and methods

Materials
Purification of the anti-inflammatory peptide
Fractionation of lupine protein hydrolysates by ultrafiltration
LPH was fractionated through an ultrafiltration membrane with a molecular weight cutoff of 10 kDa. Two fractions were recovered, lyophilised, and named MW1 (retentate, molecular weight >10 kDa) and MW2 (permeate, molecular weight <10 kDa).
Purification of anti-inflammatory peptides by reversed-phase chromatography
The fraction exhibiting the highest anti-inflammatory activity after ultrafiltration was further purified on a Resource RPC 3 mL column (GE Healthcare, Uppsala, Sweden).
The injection volume was 0.5 mL, and the sample concentration was 30 mg/mL. The Seventeen fractions (F1-F17) were collected, dried under a nitrogen stream to remove ACN and TFA, and lyophilised.
Purification of anti-inflammatory peptides by gel filtration chromatography.
The most active fraction obtained from reversed-phase chromatography was further purified on a Superdex TM peptide 10/300 GL column (GE Healthcare). The injection volume was 0.5 mL, and the sample concentration was 10 mg/mL. The buffer used as eluent was 2% ACN and 0.065% TFA at a flow rate of 1.0 mL/min. Elution was monitored at 214 nm, and five fractions (F3-1 to F3-5) were collected, dried under a nitrogen stream, and lyophilised. The sequence of the purified peptide was identified through sequence analysis by nanoHPLC coupled to a Polaris Q ion-trap mass spectrometer (Mass Spectrometry Unit, Instituto de la Grasa, Sevilla, Spain).
Amino acid sequence identification
Cell culture and treatments
The human monocytic THP-1 cell line in suspension was cultured at 37º C and 5% CO 2 in RPMI medium 1640 supplemented with 1% P/S and 10% heat-inactivated FBS.
Monocytes were differentiated and polarised to classically activated M1 macrophages by incubation with PMA (100 nmol/L) for 4 days. PMA-stimulated THP-1 cells (referred to as THP-1-derived macrophages) were exposed to RPMI medium (supplemented with 1% FBS) for 24 h and then treated with the samples at a concentration of 500 μg/mL RPMI medium (1% FBS) for 6 h. In the case of the synthetic peptide two concentrations (100 and 500 μg/mL) and two incubation times (6 and 48 h) were tested. Control without sample was only composed of RPMI medium (1% FBS).
Cell viability
The reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to formazan was used to asses possible cytotoxic effect on THP-1-derived macrophages.
mRNA extraction and analysis of PCR products
Total RNA was extracted from THP-1-derived macrophages using NucleoSpin ® RNA
II. RNA quality was assessed by the OD260:OD280 ratio in a NanoDrop ND-1000
Spectrophotometer (Thermo Scientific, Waltham, MA, USA). One microgram of total RNA was subjected to RT-PCR to obtain cDNA according to the manufacturers' protocol.
The mRNA levels for specific genes were determined on an Mx3000P system (Stratagene, La Jolla, CA, USA). All reactions were performed in triplicate in a total (300 nM final concentration), 5 µL of diethylpyrocarbonate-treated water and 2 µL of template cDNA (10 ng). The reference genes HPRT and GAPDH were used to correct for RNA concentration differences between the samples.
The thermal cycling conditions were as follows: 95º C for 10 min, 40 cycles of 95º C for 30 s, 56º C for 1 min and 72º C for 30 s.
The magnitude of the change in mRNA expression for candidate genes was calculated using the standard 2 -(ΔΔCt) method. All data were normalised to endogenous reference (HPRT and GAPDH) gene levels and expressed as percentages of the control.
Enzyme-linked immunosorbent assay (ELISA).
TNF, IL-1β and IL10 concentrations in cell culture supernatants were quantified using commercial ELISA kits according to the manufacturer's instructions.
Synthesis of the peptide
The peptide was synthesised by Fmoc solid-phase method by the Barcelona Scientific Park Foundation (Barcelona, Spain) at 95% purity, measured by HPLC-UV at 220 nm.
Measurements of nitrite in THP-1-derived macrophages cells.
As an indicator of NO production, nitrite (NO 2 -) concentration was measured in the cell culture supernatants. Equal volumes of culture supernatants and Griess reagent were mixed and the absorbance was read at 540 nm in the microplate reader (Green, Wagner, Glogowski, Skipper, Wishnok, & Tannenbaum, 1981) . The amount of nitrite was obtained by an extrapolation from a standard curve with sodium nitrite.
Statistical analysis
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Bonferroni test. Differences were considered to be significant at P <0.05.
Results and discussion
Purification of anti-inflammatory peptides from LPH
We previously demonstrated that LPHs obtained using commercial proteases inhibited the activity of some of the enzymes involved in the inflammatory pathway, such as phospholipase A 2 , cyclooxygenase-2, transglutaminase and thrombin (Millán-Linares et al., 2014b) . These results were subsequently confirmed by the reduction of cytokine expression in THP-1-derived macrophages, and this was the first report to describe the anti-inflammatory effect in these cells and influence the control of macrophage polarisation in the context of an inflammatory state (Millán-Linares et al., 2014a) .
We concluded that LPH, obtained by the enzymatic hydrolysis of lupine protein isolate with Alcalase, is a good raw material for the purification and identification of antiinflammatory peptides from lupine.
Purification of peptides by ultrafiltration
Ultrafiltration processes are used to purify bioactive peptides from protein hydrolysates (Majumder & Wu, 2011; Vo, Ryu & Kim, 2013) . The LPH produced after hydrolysis with Alcalase 2.4 L (as described in 2.3) was used as the substrate for the purification of anti-inflammatory peptides by ultrafiltration with a membrane with a molecular weight cut-off of 10 kDa, and two fractions were obtained: retentate with a molecular weight >10 kDa (MW1) and permeate with a molecular weight <10 kDa (MW2) representing, respectively, 15.72 and 84.28% of the mass recovered after the ultrafiltration process.
The effect of these two fractions on the expression of TNF, IL-1β, IL-6, CCR2, CCL2
(pro-inflammatory cytokines) and CCL18 (anti-inflammatory cytokine) was evaluated by qPCR relative to a control without treatment (Figure 1) . Expression of TNF (Figure 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 ultrafiltration. So, MW1 induced the down-regulation of TNF and CCL2 in activated macrophages by 41 and 32%, respectively, whereas MW2 reduced by 50% the expression of these two cytokines. Expression of the other pro-inflammatory cytokines, except CCR2, was also repressed, although significant differences were not observed.
Both fractions seemed to induce CCL18 expression, but this up-regulated expression was not significant ( Figure 1F ). Considering these results, the higher mass recovery, and the fact that peptides with a relatively low molecular weight seem to show a higher intestinal absorption and bioavailability (Roberts, Burney, Negro, & Zaloga, 1999 ), MW2 (< 10 kDa) was chosen for the next purification step.
Purification of MW2 by reversed-phase chromatography
MW2 was used for further purification of anti-inflammatory peptides by reversed-phase chromatography (Seber et al., 2012 respectively. Fractions F1-F5 corresponded to unbound peptides and constituted almost 51% of the total mass. Fractions F6-F17 were composed of peptides with increasing hydrophobicity and represented 49% of the total mass. The potential anti-inflammatory activity of all these fractions were tested by measuring the expression of TNF and IL-1β by qPCR, and was "yes" (Y) when the fractions down-regulated cytokine expression and "no" (N) when the fractions did not down-regulate cytokine expression (Figure 2 ).
Only F3 and F7 reduced the gene expression of both cytokines. The expression of cytokines IL-6, CCR2, CCL2 and CCL18 was then evaluated to verify which of the two fractions may have greater anti-inflammatory potential. Expression of CCR2, which had not been reduced by the ultrafiltration fractions, and CCL2 was strongly repressed by both fractions (Figures 3B and 3C ). In fact, F3 reduced the expression of CCR2 and   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 CCL2 by 55 and 39%, and F7 induced the down-regulation of both cytokines at more than 70%. Moreover, IL-6 expression was significantly reduced with respect to the control by F3 and F7 (-52 and -66%, respectively) ( Figure 3A) , and the expression of CCL18 was up-regulated ( Figure 3D ) by the two fractions above 100%. Ultimately, F3
was selected for further purification because it had a recovery rate nearly twice that of the F7 fraction.
Purification of F3 by gel filtration chromatography
Gel filtration chromatography has been used in numerous studies for the purification and identification of bioactive peptides from the protein hydrolysates of several sources, down-regulated TNF expression, and thus, this fraction was selected for the rest of the analyses. Although no significant differences were observed in IL-6 expression ( Figure   5A ), F3-5 dramatically reduced CCR2 and CCL2 expression, -59.54% and -74.45%, respectively ( Figures 5B and 5C ). These results indicate that F3-5 tends to decrease the pro-inflammatory capacity of activated M1 macrophages by diminishing the expression of cytokines involved in pro-inflammatory processes. Regarding anti-inflammatory cytokines, CCL18 and IL-10 ( Figures 5D and 5E ) levels were significantly up-regulated by the same fraction, and this up-regulation was higher for IL-10 (184% vs 53% for CCL18), an anti-inflammatory cytokine with a crucial role in preventing inflammatory and autoimmune pathologies (Moore, de Waal Malefyt, Coffman, & O'Garra, 2011 (Mukhopadhya et al., 2014) , and anti-inflammatory peptides with molecular weight lower than 1 kDa have been isolated from microalgae and aquatic organisms (Lee et al., 2012; Vo et al., 2013; Ahn, Cho, & Je, 2015) .
Due to the low number of sequenced anti-inflammatory peptides, it was not possible establish a correlation between the anti-inflammatory activity and any amino acid. As in the case of lunasin, it is probably that the sequence we have identified could be present in other plant proteins.
The peptide was synthesised for further studies in the determination and expression of cytokines by qPCR and ELISA.
Anti-inflammatory activity of the synthetic peptide
THP-1-derived macrophages were treated with the synthetic peptide at two different concentrations: 100 µg/mL (P1) and 500 µg/mL (P2). Viability of cells treated with the peptide was not significantly reduced at peptide concentrations ranging 100-2000 µg/mL.
Measurement of cytokine expression by qPCR
The expression of TNF ( Figure 6A ) and IL-1β ( Figure 6B ) was significantly suppressed compared to the control by 40%, and significant differences were not observed between the different concentrations. Neither P1 nor P2 significantly modified the IL-6 gene   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 expression ( Figure 6C ). Furthermore, the synthetic peptide significantly reduced CCL2 expression at both concentrations by 50% ( Figure 6D ). The receptor CCR2 only showed significant differences compared to the control after treatment at concentration P1
( Figure 6E ).
Regarding the expression of anti-inflammatory cytokines, only IL-10 was induced by the synthetic peptide at both concentrations ( Figure 7B ). These results are slightly different with respect to the purified fraction F3-5 because CCL18 expression obtained by qPCR was higher than the control and the synthetic peptide did not up-regulate CCL18 expression at any of the concentrations used ( Figure 7A ). These small differences in the expression of pro-and anti-inflammatory cytokines between F3-5 (obtained from LPH after purification by ultrafiltration and chromatography) and the synthetic peptide could be due to the interaction of cells with any minor differences in amino acid sequence from the synthetic peptide.
Determination of cytokine production by ELISA
The concentration of TNF, IL-1β and IL-10 was determined in the supernatants of cell cultures after treatment with the synthetic peptide at concentrations P1 and P2 for 6 and 48 h to observe possible fluctuations in protein levels. The production of TNF and IL-1β decreased significantly (-42 and -39%, respectively) compared to the control after 6 h of treatment with the peptide at 100 µg/mL, whereas P2 did not result in any significant differences with respect to the control ( Figures 8A1 and 8B1, respectively) . However, the decrease in TNF and IL-1β due to P1 was not observed in the supernatant of the cell culture after 48 h ( Figures 8A2 and 8B2 ). In contrast, the production of IL-10 only increased after 48 h ( Figure 8C2 ) and was significantly different from the control in P1.
The lowest dose of the peptide, P1 (100 µg/mL), acted both at the transcriptional and posttranscriptional levels, exerting an anti-inflammatory effect in the short term (6 h) by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 inhibiting TNF and IL-1β secretion and in the long-term (48 h) by inducing the secretion of the anti-inflammatory cytokine IL-10.
Effect of the synthetic peptide on nitrite production
Nitric oxide has been shown to play a central role in inflammatory and immune reaction activities and macrophages appear to be the main cellular source of NO (Montserrat-de la Paz, Fernández-Arche, Ángel-Martín & García-Giménez, 2012) . The effect of the synthetic peptide on the release of this inflammatory mediator is depicted in Figure 9 .
Both concentrations inhibited the NO production; although the highest concentration of peptide seemed to show highest inhibition, there was no statistical difference between P1 and P2. Similar results were obtained by Ahn et al (2015) , who reported that the treatment with peptide PAY (purified from salmon byproduct hydrolysates) at 0.25 mM (≈0.1 mg/mL) reduced by 57% the NO production in LPS-stimulated RAW264.7 macrophages. These authors described that the inhibition was in a dose dependent manner, although there was not statistical difference at concentrations higher than 0.5 mM.
In conclusion, an anti-inflammatory octapeptide was purified from a L. angustifolius protein hydrolysate by ultrafiltration and reversed-phase and gel filtration chromatographies. The sequence was identified as Gly-Pro-Glu-Thr-Ala-Phe-Leu-Arg, and the peptide was synthesised. Anti-inflammatory activity of the synthetic peptide was corroborated by studying the expression of cytokines by qPCR, the levels of these proteins by ELISA, and the inhibition of NO production in THP-1-derived macrophages. To the best of our knowledge, this is the first report of an antiinflammatory peptide purified from a L. angustifolius protein hydrolysate. Further investigations on in vivo studies of these activities would be necessary to establish   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15 strategies for specific pathophysiological conditions that could mark the possible use of these compounds in specialised nutrition. Kovacs-Nolan, J., Zhang, H., Ibuki, M., Nakamori, T., Yoshiura, K., Turner, P. V., 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 , and IL-10 (C) production of THP-1-derived macrophages after 6 h (1) and 48 h (2) of treatment with a peptide concentration of 100 µg/mL (P1) and 500 µg/mL (P2). Values marked with different letters are significantly different (P < 0.05). Figure 9 . NO production (%) in THP-1-derived macrophages after 48 h of treatment with a peptide concentration of 100 µg/mL (P1) and 500 µg/mL (P2). Values marked with different letters are significantly different (P < 0.05).
